Analysis of candidate genes for prostate cancer

Human Heredity

Volumn 57, Issue 4, 2004, Pages 172-178

  Burmester, James K ^a   Suarez, Brian K ^b   Lin, Jennifer H ^c   Jin, Carol H ^b   Miller, Raymond D ^d   Zhang, Kai Qi ^a   Salzman, Sherry A ^a   Reding, Douglas J ^a   Catalona, William J ^e  

^a MARSHFIELD CLINIC   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d WASHINGTON UNIVERSITY   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Aggressiveness; Familial disease; Genetics; Metastasis; Prostate cancer; Single nucleotide polymorphism

Indexed keywords

CAVEOLIN 2; EPITHELIAL MEMBRANE ANTIGEN; MESSENGER RNA; PROSTATE SPECIFIC ANTIGEN; PROTEIN MLH1;

AGED; ARTICLE; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DNA BINDING; FAMILY HISTORY; GENE EXPRESSION; GENE FREQUENCY; GENETIC LINKAGE; GENOTYPE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; RECTUM;

GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LIKELIHOOD FUNCTIONS; MALE; NEOPLASM INVASIVENESS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS;

EID: 10844257342     PISSN: 00015652     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081443     Document Type: Article

References (30)

1. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ: Cancer statistics, 2003. CA Cancer J Clin 2003;53:5-26.
2. Catalona WJ, Antenor JA, Roehl KA, Moul JW: Screening for prostate cancer in high risk populations. J Urol 2002;168:1980-1983.
3. Keetch DW, Humphrey PA, Smith DS, Stahl D, Catalona WJ: Clinical and pathological features of hereditary prostate cancer. J Urol 1996:155:1841-1843.
4. Carter BS, Beaty TH, Steinberg GD, Childs B, Walsh PC: Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA 1992;89:3367-3371.
5. Ostrander EA, Stanford JL: Genetics of prostate cancer: too many loci, too few genes. Am J Hum Genet 2000;67:1367-1375.
6. Easton DF, Schaid DJ, Whittemore AS, Isaacs WJ; International Consortium for Prostate Cancer Genetics: Where are the prostate cancer genes? - A summary of eight genome wide searches. Prostate 2003;57:261-269.
7. Suarez BK, Lin J, Burmester JK, Broman KW, Weber JL, Banerjee TK, Goddard KA, Witte JS, Elston RC, Catalona WJ: A genome screen of multiplex sibships with prostate cancer. Am J Hum Genet 2000;66:933-944.
8. Suarez BK, Lin J, Witte, JS, Conti DV, Resnick MI, Klein EA, Burmester JK, Vaske DA, Banerjee TK, Catalona WJ: Replication linkage study for prostate cancer susceptibility genes. Prostate 2000;45:106-114.
9. Goddard KA, Witte JS, Suarez BK, Catalona WJ, Olson JM: Model-free linkage analysis with covariates confirms linkage of prostate cancer to chromosomes 1 and 4. Am J Hum Genet 2001;68:1197-1206.
10. Witte JS, Goddard KA, Conti DV, Elston RC, Lin J, Suarez BK, Broman KW, Burmester JK, Weber JL, Catalona WJ: Genomewide scan for prostate cancer-aggressiveness loci. Am J Hum Genet 2000;67:92-99.
11. Witte JS, Suarez BK, Thiel B, Lin J, Yu A, Banerjee TK, Burmester JK, Casey G, Catalona WJ: Genome-wide scan of brothers: replication and fine mapping of prostate cancer susceptibility and aggressiveness loci. Prostate 2003;57:298-308.
12. Smith DS, Humphrey PA, Catalona WJ: The early detection of prostate cancer with prostate specific antigen: the Washington University experience. Cancer 1997;80:1852-1856.
13. Smith JR, Freije D, Carpten JD, Gronberg H, Xu J, Isaacs SD, Brownstein MJ, Bova GS, Guo H, Bujnovszky P, Nusskern DR, Damber JE, Bergh A, Emanuelsson M, Kallioniemi OP, Walker-Daniels J, Bailey-Wilson JE, Beaty TH, Meyers DA, Walsh PC, Collins FS, Trent JM, Isaacs WB: Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science 1996;274:1371-1374.
14. Gibbs M, Stanford JL, Jarvik GP, Janer M, Badzioch M, Peters MA, Goode EL, Kolb S, Chakrabarti L, Shook M, Basom R, Ostrander EA, Hood L: A genomic scan of families with prostate cancer identifies multiple regions of interest. Am J Hum Genet 2000;67:100-109.
15. Tavtigian SV, Simard J, Teng DH, Abtin V, Baumgard M, Beck A, Camp NJ, Carillo AR, Chen Y, Dayananth P, Desrochers M, Dumont M, Farnham JM, Frank D, Frye C, Ghaffari S, Gupte JS, Hu R, Iliev D, Janecki T, Kort EN, Laity KE, Leavitt A, Leblanc G, McArthur-Morrison J, Pederson A, Penn B, Peterson KT, Reid JE, Richards S, Schroeder M, Smith R, Snyder SC, Swedlund B, Swensen J, Thomas A, Tranchant M, Woodland AM, Labrie F, Skolnick MH, Neuhausen S, Rommens J, Cannon-Albright LA: A candidate prostate cancer susceptibility gene at chromosome 17p. Nat Genet 2001;27:172-180.
16. Berry R, Schroeder JJ, French AJ, McDonnell SK, Peterson BJ, Cunningham JM, Thibodeau SN, Schaid DJ: Evidence for a prostate cancersusceptibility locus on chromosome 20. Am J Hum Genet 2000;67:82-91.
17. Ohnishi Y, Tanaka T, Ozaki K, Yamada R, Suzuki H, Nakamura Y: A high-throughput SNP typing system for genome-wide association studies. J Hum Genet 2001;46:471-477.
18. Lange K, Weeks D, Boehnke M: Programs for pedigree analysis MENDEL, FISHER and dGENE. Genet Epidemiol 1988;5:471-472.
19. Boehnke M: Allele frequency estimation from data on relatives. Am J Hum Genet 1991;48:22-25.
20. Khoury MJ, Beaty TH, Cohen BH: Fundamentals of Genetic Epidemiology. New York, Oxford University Press, 1993.
21. Lasorella A, Uo T, Iavarone A: Id proteins at the cross-road of development and cancer. Oncogene 2001;20:8326-8333.
22. Magee JA, Araki T, Patil S, Ehrig T, True L, Humphrey PA, Catalona WJ, Watson MA, Milbrandt J: Expression profiling reveals hepsin overexpression in prostate cancer. Cancer Res 2001;61:5692-5696.
23. Beardsley DI, Kowbel D, Lataxes TA, Mannino JM, Xin H, Kim WJ, Collins C, Brown KD: Characterization of the novel amplified in breast cancer-1 (NABC1) gene product. Exp Cell Res 2003;290:402-413.
24. Tang Z, Scherer PE, Okamoto T, Song K, Chu C, Kohtz DS, Nishimoto I, Lodish HF, Lisanti MP: Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J Biol Chem 1996;271:2255-2261.
25. Tahir SA, Yang G, Ebara S, Timme TL, Satoh T, Li L, Goltsov A, Ittmann M, Morrisett JD, Thompson TC: Secreted caveolin-1 stimulates cell survival/clonal growth and contributes to metastasis in androgen-insensitive prostate cancer. Cancer Res 2001;61:3882-3885.
26. Wilson HL, Wilson SA, Surprenant A, North RA: Epithelial membrane proteins induce membrane blebbing and interact with the P2X7 receptor C terminus. J Biol Chem 2002;277:34017-34023.
27. Papadopoulos N, Nicolaides NC, Wei YF, Ruben SM, Carter KC, Rosen CA, Haseltine, WA, Fleischmann RD, Fraser CM, Adams MD, Venter JC, Hamilton SR, Peterson GM, Watson P, Lynch HT, Peltomäki P, Mecklin JP, de la Chapelle A, Kinzler KW, Vogelstein B: Mutation of mutL homolog in hereditary colon cancer. Science 1994;263:1625-1629.
28. Lu ML, Schneider, MC, Zheng Y, Zhang X, Richie JP: Caveolin-1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation. J Biol Chem 2001;276:13442-13451.
29. Peltomäki P: Deficient DNA mismatch repair: a common etiologic factor for colon cancer. Hum Mol Genet 2001;10:735-740.
30. Leach FS: Microsatellite instability and prostate cancer: clinical and pathological implications. Curr Opin Urol 2002;12:407-411.